CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Provincial Funding Summary (iJODR)

The interim Joint Oncology Drug Review (iJODR) was the precursor oncology drug review process to pCODR. It provided evidence-based recommendations for cancer treatments from early 2007 until the transition to pCODR in 2010.

iJODR Drugs – Provincial Funding Summary